Long Term Use of Boosted Atazanavir (ATV/r) in Real Life: A 5 Year Retrospective Observational Belgian Cohort of 2264 HIV Patients
Stéphane De Wit(Centre Hospitalier Universitaire de Saint-Pierre), Sam Pollet, Michel Moutschen(University of Liège), Linos L. Vandekerckhove, Jean‐Christophe Goffard(Université Libre de Bruxelles), Éric Florence(Instituut voor Tropische Geneeskunde), Bernard E. Van Beers(Cliniques Universitaires Saint-Luc), Patrick Lacor, Eric Van Wijngaerden(KU Leuven), Maartje Van Frankenhuijsen, Marie‐Luce Delforge(Université Libre de Bruxelles), Rémy Demeester(Grand Charleroi Hospital)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
October 1, 2013
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Invasive Aspergillosis in Critically Ill Patients without Malignancy
|American Journal of Respiratory and Critical Care Medicine|2004|544
Deep Dermatophytosis and Inherited CARD9 Deficiency
|New England Journal of Medicine|2013|403
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium
|JAMA|2020|352
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients
|Critical Care|2020|302